Lucara Diamond Corp (LUC)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 0.950 |
|---|---|
| 52-week range | 0.876 – 2.380 |
| Return, 1 month / 3 months | −21.5% / −17.5% |
| Return, 1 year / 3 years | −25.4% / −67.2% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 53.0% |
| Worst drawdown (1 year) | -54.1% |
| Average daily value traded | 0.75M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lucara Diamond Corp is a diamond mining company that operates the Karowe mine in Botswana, where it extracts rough diamonds from an open-pit operation. The company produces large, high-value stones and sells its rough diamonds through regular tenders to cutters, polishers and dealers in the international diamond trade. Lucara is headquartered in Vancouver, Canada, and its business centres on recovering and marketing exceptional rough diamonds from its Botswana asset.
The shares are listed on the Nasdaq Stockholm in Sweden under the code LUC, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lucara Diamond Corp (LUC) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 0.950 on 27 October 2026.
Its price-based Market X-Ray is 33 out of 100 (a weak price profile), ranking 680 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.4% and over the last three months it fell 17.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -32.8% | ||
| From 52-week high | -52.4% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.5% | ||
| 6-month return | -44.8% | ||
| 12-month return, skipping the last month | -5.0% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.1% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.75M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +3.8% |
|---|---|
| 1 month | −21.5% |
| 3 months | −17.5% |
| 6 months | −44.8% |
| 1 year | −25.4% |
| 3 years | −67.2% |
| 5 years | −78.0% |
Signals
| 50-day / 200-day average | 1.137 / 1.413 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.055 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Sep 2019 | CAD 0.1829 |
| 5 Jun 2019 | CAD 0.1759 |
| 21 Mar 2019 | CAD 0.1717 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.